Skip to Content

Rafael Holdings Inc Ordinary Shares - Class B RFL Stock Quote

| Rating as of

Morningstar‘s Stock Analysis RFL

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics RFL

Company Profile RFL

Business Description

Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.

Contact
520 Broad Street
Newark, NJ, 07102
T +1 212 658-1450
Industry Real Estate Services
Most Recent Earnings Apr 30, 2022
Fiscal Year End Jul 31, 2021
Stock Type Distressed
Employees 25